Answers are grounded in this paper and cite their sources.
This study estimated the burden of invasive pneumococcal disease (IPD), non-bacteraemic pneumococcal pneumonia (NBPP), and acute otitis media (AOM) prior to and after PCV13 introduction into Hong Kong’s Childhood Immunization Program (CIP) in 2011. Episodes of eligible children aged <18 years hospitalised with IPD, NBPP, or AOM from 2005 to 2019 were identified from the Clinical Data Analysis and Reporting System in Hong Kong. Annual hospitalised incidence rate, case fatality rate, and healthcare resource utilisation and costs were estimated. Incidence time trends were assessed with interrupted time series analyses. One hundred and seventy-eight IPD episodes, 1198 NBPP episodes and 7025 AOM episodes were identified. The overall annual incidence rates of IPD, NBPP, AOM were 1.37, 9.21, and 53.98 episodes per 100000 person-years, respectively. Interrupted time series analyses results showed a reduction in trend of incidence rate (incidence rate ratio (IRR): 0.97, 95% confidence interval (CI): 0.94–0.99) but not in baseline incidence rate for NBPP. No difference in baseline incidence rates and trends between the two periods was observed for IPD and AOM. Case fatality rate was 3.37%, 0.50%, and 0.00% for IPD, NBPP, and AOM, respectively. Burden of pneumococcal diseases among children remained high after PCV13 introduction into Hong Kong’s CIP.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: